ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

GSK Adds In Singapore, Shrinks In China

by Jean-François Tremblay
March 16, 2015 | APPEARED IN VOLUME 93, ISSUE 11

GlaxoSmithKline will set up new Asian headquarters in a building in Singapore large enough to accommodate 1,000 people. The company currently employs 700 office workers in the city-state. It also operates three plants and performs R&D there. In China, meanwhile, 110 GSK staffers were let go for violating the firm’s ethical guidelines, according to local reports. In a statement, GSK did not confirm how many people it dismissed but said it took “disciplinary actions against employees whose conduct contravened GSK’s values and code of conduct.” The improper events took place in 2013, GSK noted. Last September, China fined GSK $500 million and found four company managers guilty of paying bribes.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment